On April 3, 2023, Jin-Long Chen, Ph.D. resigned as Chief Scientific Officer of NGM Biopharmaceuticals, Inc., and as a member of the Board, in each case effective as of April 4, 2023. The Board has accepted Dr. Chen's resignation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 USD | -1.28% |
|
-.--% | +79.28% |
1st Jan change | Capi. | |
---|---|---|
+79.28% | 129M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- NGM Stock
- News NGM Biopharmaceuticals, Inc.
- Jin-Long Chen, Ph.D. Resigns as Chief Scientific Officer of NGM Biopharmaceuticals, Inc., and as A Member of the Board